Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective neonatal BCG vaccination.

D Bakshi1, N Sharief

  • 1Basildon Hospital, Essex, UK. dinkarbakshi@rediffmail.com

Acta Paediatrica (Oslo, Norway : 1992)
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute reversible hearing loss in scrub typhus.

The Journal of the Association of Physicians of India·2007
Same author

Selective neonatal BCG vaccination - a re-audit.

Acta paediatrica (Oslo, Norway : 1992)·2006
Same author

Is fragmentation of schedules hampering the uptake of hepatitis B vaccine?

Archives of disease in childhood·2005
Same author

Bacterial meningitis presenting as acute torticollis.

Acta paediatrica (Oslo, Norway : 1992)·2004
Same author

Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland.

Pediatric pulmonology·2002
Same author

Comparison of EML 105 and advantage analysers measuring capillary versus venous whole blood glucose in neonates.

Acta paediatrica (Oslo, Norway : 1992)·2001

The neonatal BCG immunization policy showed high effectiveness, with 85% of eligible newborns receiving the vaccine in the hospital. Infants not immunized at birth rarely receive the BCG vaccine later.

Area of Science:

  • Public Health
  • Immunology
  • Pediatrics

Background:

  • The implementation of selective neonatal BCG immunization policies is crucial for disease prevention.
  • Understanding vaccine uptake and compliance is essential for public health strategies.

Purpose of the Study:

  • To evaluate the effectiveness of the "Selective Neonatal BCG Immunisation Policy."
  • To identify reasons for non-compliance or failure in BCG vaccine uptake among newborns.

Main Methods:

  • Utilized Birth Register data to identify eligible neonates within Basildon and Thurrock NHS Trust (2001).
  • Employed Community Child Health computer records to determine BCG immunization status.

Main Results:

  • The study included 201 neonates eligible for BCG immunization.

Related Experiment Videos

  • A high uptake rate of 85% was observed, with 171 neonates receiving BCG in the neonatal period.
  • Most vaccinations (169) occurred before hospital discharge; only 2 occurred in the community.

    • Conclusions:

    • The "Neonatal BCG Immunisation Policy" is effective in achieving high in-hospital vaccination rates.
    • Neonates not immunized in the hospital setting have a low likelihood of receiving the BCG vaccine in the community.